AVIVA PLC

Position in KRYS — Krystal Biotech, Inc.

CIK 1140022 LONDON, X0

Position in KRYS

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$503,612

+$66,793 QoQ

Shares Held

1,355

-19.9% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#245

of 419 holders

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

AVIVA PLC holds $285,082,134 across 22 Biotechnology names. KRYS ranks #13 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	223,593	$111,065,350
2	REGN	Regeneron Pharmaceuticals, Inc.	91,486	$57,045,180
3	ALNY	Alnylam Pharmaceuticals, Inc.	114,532	$34,477,567
4	RVMD	Revolution Medicines, Inc.	118,070	$22,112,149
5	RPRX	Royalty Pharma plc	359,125	$20,136,138
6	INCY	Incyte Corp	148,924	$16,882,024
7	INSM	INSMED Inc	144,131	$15,367,247
8	LEGN	Legend Biotech Corp	53,486	$1,544,675

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$503,612	1,355	-19.9%	Shares	Defined	2026-08-13
2026-03-31	$436,819	1,691	-24.1%	Shares	Defined	2026-05-14
2025-12-31	$549,291	2,228	-31.0%	Shares	Defined	2026-02-12
2025-09-30	$570,368	3,231	-9.6%	Shares	Defined	2025-11-13
2025-06-30	$491,419	3,575	+9.8%	Shares	Defined	2025-08-07
2025-03-31	$587,056	3,256	-81.1%	Shares	Defined	2025-05-15
2021-03-31	$1,324,933	17,198	-40.9%	Shares	Defined	2021-05-13
2020-12-31	$1,745,640	29,094	-44.8%	Shares	Defined	2021-02-10
2020-09-30	$2,267,787	52,678	-4.7%	Shares	Defined	2020-11-12
2020-06-30	$2,290,484	55,299	-40.5%	Shares	Defined	2020-08-13
2020-03-31	$4,018,855	92,943	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.